Sugammadex, the first selective relaxant binding agent for neuromuscular block reversal

Drugs of Today

Volumn 48, Issue 6, 2012, Pages 405-413

  Stair, C ^a   Fernandez Bustamante, Ana ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Cyclodextrin; Neuromuscular blockade; Neuromuscular blocking agents; Neuromuscular paralysis reversal; Selective reversal binding agent; Sugammadex

Indexed keywords

NEOSTIGMINE; PANCURONIUM; ROCURONIUM; SUGAMMADEX; VECURONIUM; CHOLINESTERASE INHIBITOR; NEUROMUSCULAR BLOCKING AGENT;

BINDING AFFINITY; BRADYCARDIA; DERMATOMYOSITIS; DIARRHEA; DRUG BINDING; DRUG CLEARANCE; DRUG CONTRAINDICATION; DRUG COST; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG METABOLISM; DRUG SAFETY; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG TOLERABILITY; DYSGEUSIA; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; KIDNEY FAILURE; LIVER FAILURE; MUSCLE RELAXATION; NEUROMUSCULAR BLOCKING; OBESITY; PARALYSIS; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHASE 4 CLINICAL TRIAL (TOPIC); PREGNANCY; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

CHOLINESTERASE INHIBITORS; HUMANS; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS;

EID: 84864856048     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2012.48.6.1813474     Document Type: Review

References (39)

1. Perry, J., Lee, J., Sillberg, V., Wells, G. Rocuronium versus succhinylcholine for rapid sequence induction intubation. Cochrane Database Syst Rev 2008, CD002788.
2. Han, T.H., Martyn, J.A. Onset and effectiveness of rocuronium for rapid onset of paralysis in patients with major burns: priming or large bolus. Br J Anaesth 2009, 102(1): 55-60.
3. Miller, R.D. Miller's Anesthesia. 7th ed. Churchill Livingstone/Elsevier: Philadelphia, PA 2010.
4. Duvaldestin, P., Plaud, B. Sugammadex in anesthesia practice. Expert Opin Pharmacother 2010, 11(16): 2759-71.
5. Bom, A., Bradley, M., Cameron, K. et al. A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl 2002, 41(2): 266-70.
6. Naguib, M. Sugammadex: another milestone in clinical neuromuscular pharmacology. Anesth Analg 2007, 104(3): 575-81. (Pubitemid 46331731)
7. Staals, L.M., Snoeck, M.M., Driessen, J.J., van Hamersvelt, H.W., Flockton, E.A., van den Heuvel, M.W., Hunter, J.M. Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study. Br J Anaesth 2010, 104(1): 31-9.
8. Sparr, H.J., Vermeyen, K.M., Beaufort, A.M. et al. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics. Anesthesiology 2007, 106(5): 935-43. (Pubitemid 46684059)
9. Staals, L.M., de Boer, H.D., van Egmond, J. et al. Reversal of rocuronium-induced neuromuscular block by sugammadex is independent of renal perfusion in anesthetized cats. J Anesth 2011, 25(2): 241-6.
10. Epemolu, O., Bom, A., Hope, F., Mason, R. Reversal of neuromuscular blockade and simultaneous increase in plasma rocuronium concentration after the intravenous infusion of the novel reversal agent Org 25969. Anesthesiology 2003, 99(3): 632-7. (Pubitemid 37051978)
11. Sorgenfrei, I.F., Norrild, K., Larsen, P.B., Stensballe, J., Ostergaard, D., Prins, M.E., Viby-Mogensen, J. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study. Anesthesiology 2006, 104(4): 667-74.
12. Groudine, S.B., Soto, R., Lien, C., Drover, D., Roberts, K. A randomized, dose-finding, phase II study of the selective relaxant binding drug, Sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block. Anesth Analg 2007, 104(3): 555-62.
13. Duvaldestin, P., Kuizenga, K., Saldien, V. et al. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia. Anesth Analg 2010, 110(1): 74-82.
14. Sorensen, M.K., Bretlau, C., Gatke, M.R., Sorensen, A.M., Rasmussen, L.S. Rapid sequence induction and intubation with rocuronium-sugammadex compared with succinylcholine: a randomized trial. Br J Anaesth 2012, 108(4): 682-9.
15. Lee, C., Jahr, J.S., Candiotti, K.A., Warriner, B., Zornow, M.H., Naguib, M. Reversal of profound neuromuscular block by sugammadex administered three minutes after rocuronium: a comparison with spontaneous recovery from succinylcholine. Anesthesiology 2009, 110(5): 1020-5.
16. Deckert, D., Lederer, W., Khuenl-Brady, K.S. Unexpected failure of rocuronium-mediated neuromuscular blockade. Anaesthesia 2011, 66(1): 58-9.
17. Gaszynski, T., Szewczyk, T., Gaszynski, W. Randomized comparison of sugammadex and neostigmine for reversal of rocuronium-induced muscle relaxation in morbidly obese undergoing general anaesthesia. Br J Anaesth 2012, 108(2): 236-9.
18. Le Corre, F., Nejmeddine, S., Fatahine, C., Tayar, C., Marty, J., Plaud, B. Recurarization after sugammadex reversal in an obese patient. Can J Anaesth 2011, 58(10): 944-7.
19. Plaud, B., Meretoja, O., Hofmockel, R. et al. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients. Anesthesiology 2009, 110(2): 284-94.
20. Dahl, V., Pendeville, P.E., Hollmann, M.W., Heier, T., Abels, E.A., Blobner, M. Safety and efficacy of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in cardiac patients undergoing noncardiac surgery. Eur J Anaesthesiol 2009, 26(10): 874-84.
21. de Kam, P.J., van Kuijk, J., Prohn, M., Thomsen, T., Peeters, P. Effects of sugammadex doses up to 32 mg/kg alone or in combination with rocuronium or vecuronium on QTc prolongation: a thorough QTc study. Clin Drug Investig 2010, 30(9): 599-611.
22. Hemmerling, T.M., Zaouter, C., Geldner, G., Nauheimer, D. Sugammadex-a short review and clinical recommendations for the cardiac anesthesiologist. Ann Card Anaesth 2010, 13(3): 206-16.
23. Williamson, R.M., Mallaiah, S., Barclay, P. Rocuronium and sugammadex for rapid sequence induction of obstetric general anaesthesia. Acta Anaesthesiol Scand 2011, 55(6): 694-9.
24. Suzuki, T., Nameki, K., Shimizu, H., Shimizu, Y., Nakamura, R., Ogawa, S. Efficacy of rocuronium and sugammadex in a patient with dermatomyositis. Br J Anaesth 2012, 108(4): 703.
25. Heier, T., Feiner, J.R., Lin, J., Brown, R., Caldwell, J.E. Hemoglobin desaturation after succinylcholine-induced apnea: a study of the recovery of spontaneous ventilation in healthy volunteers. Anesthesiology 2001, 94(5): 754-9. (Pubitemid 32429743)
26. Benumof, J.L. Preoxygenation: best method for both efficacy and efficiency. Anesthesiology 1999, 91(3): 603-5. (Pubitemid 29418635)
27. Hayes, A.H., Mirakhur, R.K., Breslin, D.S., Reid, J.E., McCourt, K.C. Postoperative residual block after intermediate-acting neuromuscular blocking drugs. Anaesthesia 2001, 56(4): 312-8. (Pubitemid 32293887)
28. Mertes, P.M., Tajima, K., Regnier-Kimmoun, M.A., Lambert, M., Iohom, G., Gueant-Rodriguez, R.M., Malinovsky, J.M. Perioperative anaphylaxis. Med Clin North Am 2010, 94(4): 761-89, xi.
29. Motamed, C., Baguenard, P., Bourgain, J.L. Possible mitigation of rocuronium-induced anaphylaxis after administration of sugammadex. J Anaesthesiol Clin Pharmacol 2012, 28(1): 127-8.
30. Lenz, A., Hill, G., White, P.F. Emergency use of sugammadex after failure of standard reversal drugs. Anesth Analg 2007, 104(3): 585-6.
31. de Boer, H.D., van Egmond, J., van de Pol, F., Bom, A., Booij, L.H. Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey. Br J Anaesth 2006, 96(4): 473-9.
32. Cammu, G., De Kam, P.J., Demeyer, I., Decoopman, M., Peeters, P.A., Smeets, J.M., Foubert, L. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers. Br J Anaesth 2008, 100(3): 373-9. (Pubitemid 351773650)
33. de Boer, H.D., Driessen, J.J., Marcus, M.A., Kerkkamp, H., Heeringa, M., Klimek, M. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study. Anesthesiology 2007, 107(2): 239-44. (Pubitemid 47196486)
34. Naguib, M., Brull, S.J. Update on neuromuscular pharmacology. Curr Opin Anaesthesiol 2009, 22(4): 483-90.
35. Menendez-Ozcoidi, L., Ortiz-Gomez, J.R., Olaguibel-Ribero, J.M., Salvador-Bravo, M.J. Allergy to low dose sugammadex. Anaesthesia 2011, 66(3): 217-9.
36. Recovery effect of sugammadex measured by bispectral and neurosense indices (Sugarecovery) (NCT01161004). ClinicalTrials.gov Web site. Accessed April 17, 2012.
37. Efficacy of sugammadex in magnesium pretreated patients (MagSug) (NCT01440933). ClinicalTrials.gov Web site. Accessed April 17, 2012.
38. Paton, F., Paulden, M., Chambers, D. et al. Sugammadex compared with neostigmine/glycopyrrolate for routine reversal of neuromuscular block: a systematic review and economic evaluation. Br J Anaesth 2010, 105(5): 558-67.
39. Chambers, D., Paulden, M., Paton, F. et al. Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment. Health Technol Assess 2010, 14(39): 1-211.